Editorial
Welcome to eurotimes.org an online service for ophthalmologists supported by the European Cataract and Refractive Surgeons Society (ESCRS).
Founded in 1991, the ESCRS is Europe's leading organisation for cataract and refractive surgeons and is at the forefront of developments in anterior segment surgery. The society currently has more than 4,000 members from over 90 different countries worldwide. The ESCRS offers a unique forum for discussion and learning which ensures that international expertise is shared by ophthalmologists all over Europe.
This website includes content from EuroTimes, the official news magazine of the ESCRS, and also links to our other online activities including Podcasts, Facebook and Twitter. As Chairman of the ESCRS Publications Committee, and also on behalf of my fellow Editors Jose Guell, Ioannis Pallikaris, Clive Peckar and Paul Rosen, I welcome the views and comments from ophthalmologists visiting the website as to how we can maintain and improve our online services.
Thank you for your support
Emanuel Rosen, ESCRS Publications Committee Chairman
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.